NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that its third quarter revenues jumped 100 percent year over year and the number of clinical tests reported grew 149 percent.

The Cambridge, Mass.-based cancer genomic analysis firm reported total revenues of $16.4 million for the three months ended Sept. 30, up from $8.2 million in Q3 2013 and $14.5 million in Q2 2014. It beat the consensus Wall Street estimate for revenues of $15.7 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.